Amgen Inc. (AMGN)
NASDAQ: AMGN
· Real-Time Price · USD
296.01
5.72 (1.97%)
At close: Aug 15, 2025, 3:43 PM
Amgen Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.17B | 8.15B | 9.09B | 8.5B | 8.39B | 7.45B | 8.2B | 6.9B | 6.99B | 6.11B | 6.84B | 6.65B | 6.59B | 6.24B | 6.85B | 6.71B | 6.53B | 5.9B |
Cost of Revenue | 3.01B | 2.97B | 3.11B | 3.31B | 3.24B | 3.2B | 3.11B | 1.81B | 1.81B | 1.72B | 1.75B | 1.59B | 1.51B | 1.56B | 1.72B | 1.61B | 1.64B | 1.49B |
Gross Profit | 6.16B | 5.18B | 5.97B | 5.19B | 5.15B | 4.25B | 5.08B | 5.1B | 5.17B | 4.38B | 5.09B | 5.06B | 5.08B | 4.68B | 5.13B | 5.1B | 4.89B | 4.41B |
Operating Income | 2.64B | 1.18B | 2.31B | 2.05B | 1.91B | 991M | 1.27B | 2.02B | 2.68B | 1.92B | 2.23B | 2.66B | 2.18B | 2.5B | 2.3B | 2.38B | 828M | 2.13B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 1.57B | 1.97B | 782M | 3.1B | 794M | -68M | 852M | 1.95B | 1.61B | 3.44B | 1.75B | 2.39B | 1.53B | 1.68B | 2.13B | 2.15B | 558M | 1.86B |
Net Income | 1.43B | 1.73B | 627M | 2.83B | 746M | -113M | 767M | 1.73B | 1.38B | 2.84B | 1.62B | 2.14B | 1.32B | 1.48B | 1.9B | 1.88B | 464M | 1.65B |
Selling & General & Admin | 1.69B | 1.69B | 1.88B | 1.63B | 1.78B | 1.81B | 2.27B | 1.35B | 1.29B | 1.26B | 1.57B | 1.29B | 1.33B | 1.23B | 1.43B | 1.3B | 1.38B | 1.25B |
Research & Development | 1.74B | 1.49B | 1.72B | 1.45B | 1.45B | 1.34B | 1.53B | 1.08B | 1.11B | 1.06B | 1.32B | 1.11B | 1.04B | 959M | 1.35B | 1.42B | 1.08B | 967M |
Other Expenses | 77M | 830M | 61M | 71M | 11M | 105M | 5M | 644M | 82M | 148M | -34M | 5M | 542M | -10M | 51M | -8M | 1.59B | 61M |
Operating Expenses | 3.51B | 4B | 3.66B | 3.15B | 3.24B | 3.26B | 3.81B | 3.08B | 2.49B | 2.46B | 2.86B | 2.4B | 2.91B | 2.18B | 2.82B | 2.72B | 4.06B | 2.28B |
Interest Expense | 708M | 723M | 747M | 776M | 808M | 824M | 821M | 759M | 752M | 543M | 415M | 368M | 328M | 295M | 335M | 296M | 281M | 285M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.52B | 6.97B | 6.78B | 6.46B | 6.48B | 6.46B | 6.92B | 4.88B | 4.3B | 4.18B | 4.61B | 3.99B | 4.42B | 3.74B | 4.54B | 4.33B | 5.7B | 3.77B |
Income Tax Expense | 136M | 243M | 155M | 271M | 48M | 45M | 85M | 217M | 235M | 601M | 132M | 249M | 214M | 199M | 232M | 271M | 94M | 211M |
Shares Outstanding (Basic) | 538M | 538M | 540.52M | 537M | 537M | 536M | 535M | 535M | 535M | 534M | 535M | 535M | 535M | 548M | 562M | 567M | 573M | 577M |
Shares Outstanding (Diluted) | 541M | 541M | 542M | 542M | 541M | 536M | 540M | 538M | 537M | 538M | 539M | 538M | 537M | 551M | 565M | 570M | 576M | 581M |
EPS (Basic) | 2.66 | 3.22 | 1.16 | 5.27 | 1.39 | -0.21 | 1.43 | 3.23 | 2.58 | 5.32 | 3.02 | 4.01 | 2.46 | 2.69 | 3.38 | 3.32 | 0.81 | 2.85 |
EPS (Diluted) | 2.65 | 3.20 | 1.16 | 5.22 | 1.38 | -0.21 | 1.42 | 3.22 | 2.57 | 5.28 | 3.00 | 3.98 | 2.45 | 2.68 | 3.36 | 3.31 | 0.81 | 2.83 |
EBITDA | 3.62B | 4.08B | 2.93B | 5.27B | 3B | 2.15B | 3.05B | 3.6B | 3.26B | 4.88B | 3.07B | 3.6B | 2.69B | 2.81B | 3.32B | 3.3B | 1.69B | 2.98B |
EBIT | 2.28B | 2.7B | 1.53B | 3.88B | 1.6B | 756M | 1.67B | 2.71B | 2.37B | 3.98B | 2.16B | 2.76B | 1.86B | 1.97B | 2.47B | 2.45B | 839M | 2.14B |
Depreciation & Amortization | 1.34B | 1.39B | 1.4B | 1.4B | 1.4B | 1.4B | 1.38B | 895M | 896M | 900M | 911M | 837M | 828M | 841M | 852M | 850M | 855M | 841M |